Na+/h+exchange inhibitors for cardioprotective therapy: progress, problems and prospects
- 20 February 2002
- journal article
- review article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 39 (5) , 747-753
- https://doi.org/10.1016/s0735-1097(02)01693-5
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Effects of moderate hypothermia on sarcolemmal Na+/H+ exchanger activity and its inhibition by cariporide in cardiac ventricular myocytesBritish Journal of Pharmacology, 2001
- Ischemic Preconditioning: From Adenosine Receptor to KATP ChannelAnnual Review of Physiology, 2000
- Rational basis for use of sodium–hydrogen exchange inhibitors in myocardial ischemiaThe American Journal of Cardiology, 1999
- Bicyclic Acylguanidine Na+/H+ Antiporter InhibitorsJournal of Medicinal Chemistry, 1998
- Influence of pHiand Creatine Phosphate on α-Adrenoceptor-mediated Cardiac HypertrophyJournal of Molecular and Cellular Cardiology, 1998
- Preischaemic as well as postischaemic application of a Na+/H+ exchange inhibitor reduces infarct size in pigsCardiovascular Research, 1995
- Protective effects of HOE642, a selective sodium-hydrogen exchange subtype 1 inhibitor, on cardiac ischaemia and reperfusionCardiovascular Research, 1995
- Does reperfusion injury exist in humans?Journal of the American College of Cardiology, 1993
- Reperfusion induced injury: manifestations, mechanisms, and clinical relevanceCardiovascular Research, 1992
- The protection of the ischemic myocardium: Surgical success v clinical failure?Progress in Cardiovascular Diseases, 1988